List of Micardis drug patents

Micardis is owned by Boehringer Ingelheim.

Micardis contains Telmisartan.

Micardis has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Micardis are:

  • US8003679

Micardis was authorised for market use on 10 November, 1998.

Micardis is available in tablet;oral dosage forms.

Micardis can be used as treatment or prevention of stroke.

The generics of Micardis are possible to be released after 06 October, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8003679 BOEHRINGER INGELHEIM Use of inhibitors of the renin-angiotensin system
Oct, 2022

(3 months ago)

Drugs and Companies using TELMISARTAN ingredient

Market Authorisation Date: 10 November, 1998

Treatment: Treatment or prevention of stroke

Dosage: TABLET;ORAL

How can I launch a generic of MICARDIS before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic